Botulinum toxin type A - Protective ptosis and squint
You are here : Home > Formulary Search > Botulinum toxin type A - Protective ptosis and squint
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Injection
Formulary Status :
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important
NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.
RSFT: Opthalmology Only
SASH: Xeomin brand. Paediatric Ophthalmic use only.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Botulinum toxin type A
Indication :
Protective ptosis and squint
Group Name :
Keywords :
Strabismus
Brand Names Include :
Botox, Xeomin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (2)
15 Jul 25 -
SASH DTG
The SASH Drugs and Therapeutics Group approved the use of this drug and indication for use in paediatrics by ophthalmic consultants only.
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Other Indications
Below are listed other indications that Botulinum toxin type A is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Protective ptosis and squint.
- No records returned.